Nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Five-year follow-up from CheckMate 142.

被引：0

作者：

Overman, Michael J.

Lenz, Heinz-Josef

Andre, Thierry

Aglietta, Massimo

Wong, Mark Ka

Luppi, Gabriele

Van Cutsem, Eric

McDermott, Raymond S.

Hendlisz, Alain

Cardin, Dana Backlund

Morse, Michael

Neyns, Bart

Hill, Andrew Graham

Limon, M. Luisa

Garcia-Alfonso, Pilar

Krishnamurthy, Anuradha

Chen, Franklin

Abdullaev, Sandzhar

Soleymani, Samira

Lonardi, Sara

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] SWOG, Houston, TX USA

[3] Univ Southern Calif, Keck Sch Med, Div Med Oncol, Los Angeles, CA USA

[4] Hop St Antoine, Assistance Publ Hop Paris, Paris, France

[5] Sorbonne Univ, Paris, France

[6] Candiolo Canc Inst, Candiolo, Italy

[7] Univ Torino, Med Sch, Candiolo, Italy

[8] Westmead Hosp, Sydney, NSW, Australia

[9] Univ Hosp Modena, Modena, Italy

[10] Univ Hosp Gasthuisberg, Leuven, Belgium

[11] Katholieke Univ Leuven, Leuven, Belgium

[12] St Vincents Univ Hosp & Canc Trials Ireland, Dublin, Ireland

[13] Inst Jules Bordet, Brussels, Belgium

[14] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[15] Duke Univ, Med Ctr, Durham, NC USA

[16] Univ Ziekenhuis Brussel, Brussels, Belgium

[17] Tasman Oncol Res Ltd, Southport, Qld, Australia

[18] Hosp Univ Virgen Rocio, Seville, Spain

[19] Hosp Gral Univ Gregorio Maranon, Madrid, Spain

[20] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA

[21] Novant Hlth Canc Inst, Winston Salem, NC USA

[22] Bristol Myers Squibb, Princeton, NJ USA

[23] Ist Oncol Veneto IOV IRCSS, Padua, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3510

引用

页数：1